17.06.2020
- The German federal government is taking a 23.1% stake, worth €300 million, in privately owned biotech CureVac. It’s an unusual move for Berlin, but economics minister Peter...
Read the digital edition of CHEManager International. Simply enter the subscription number or promotional code and login. You will find your subscription number on your invoice, or a previous print edition. The promotional code is '247'.
09.06.2020
- Anglo-Swedish drugmaker AstraZeneca is weighing a merger with US biotech Gilead Sciences, the Bloomberg news agency has reported. Surpassing Bristol Myers Squibb’s $74 billion...
09.06.2020
- Pierre-Alain Ruffieux has been appointed CEO of Swiss CDMO Lonza, with effect from 1 November 2020. The new chief executive will succeed Marc Funk, who led the company from March...
08.06.2020
- With national governments racing to nail down doses of a Covid-19 vaccine – when it comes – for their own populations, the EU’s leadership is keen to make sure that its own...
05.06.2020
- Gilead Sciences has entered a 10-year partnership with oncology-focused biopharma Arcus Biosciences to develop and commercialize current and future therapeutic candidates in Arcus...
05.06.2020
- GlaxoSmithKline (GSK) has agreed to make 1 billion doses of its AS03 adjuvant available to several developers of Covid-19 vaccines and plans to increase capacity to supply enough...
03.06.2020
- Novartis's gene therapy unit AveXis has signed an agreement to produce a novel genetic COVID-19 vaccine being developed by the US-based Mass General Brigham health care system...
01.06.2020
- German Contract Development & Manufacturing Organization CordenPharma has expanded its strategic manufacturing services agreement with Moderna to include the supply of lipid...